Dyslipidemia Treatment in Diabetes Mellitus Patients / 대한내과학회지
Korean Journal of Medicine
;
: 686-689, 2014.
Article
in Korean
| WPRIM
| ID: wpr-219261
ABSTRACT
Cardiovascular disease (CVD) is the major cause of mortality and morbidity in patients with type 2 diabetes mellitus. The increased risk of CVD in subjects with type 2 diabetes mellitus involves multiple factors, including hypertension, smoking, albuminuria, and hypercholesterolemia. Of these, hypercholesterolemia is amenable to intervention. A large body of research ranging from molecular to population studies indicates that elevated low-density-lipoprotein cholesterol (LDL-C) is a major predictor of CVD, including in the population with diabetes. Despite available therapies and increased attention to hypercholesterolemia, many patients fail to achieve the LDL-C goals. A patient-tailored approach to dyslipidemia therapy, as determined by baseline LDL-C levels, is an effective strategy for achieving target LDL-C levels.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Smoke
/
Cardiovascular Diseases
/
Smoking
/
Cholesterol
/
Mortality
/
Diabetes Mellitus
/
Diabetes Mellitus, Type 2
/
Albuminuria
/
Dyslipidemias
/
Hypercholesterolemia
Type of study:
Prognostic study
Limits:
Humans
Language:
Korean
Journal:
Korean Journal of Medicine
Year:
2014
Type:
Article
Similar
MEDLINE
...
LILACS
LIS